![Ana de Cos](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Ana is an Associate in the Client Solutions team, having joined the infrastructure team as an Analyst in 2017.
Prior to Altamar, she gained experience working at the law firm CMS Albiñana & Suárez de Lezo (Madrid) and at the global technology and media travel company Big Worldwide (London).
Ana holds a Double Degree in Business Administration and Law from Universidad Autónoma de Madrid.
Ehemalige bekannte Positionen von Ana de Cos
| Unternehmen | Position | Ende |
|---|---|---|
Altamar Private Equity SGIIC SA /Private Equity/
 Altamar Private Equity SGIIC SA /Private Equity/ Investment ManagersFinance Altamar Private Equity invests in companies located across the globe. The firm targets businesses operating in the life sciences sector including biotechnology, infrastructure, medical devices, diagnostics, genomics, and digital health. It provides equity and debt financing for buyouts, secondary, special situations, and early to growth stage capital requirements. It also makes co-investments. | Private-Equity-Analyst | 01.01.2021 |
Ausbildung von Ana de Cos
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
9
Beziehungen ersten Grades
2
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Colegio Universitario de Estudios Financieros
 Colegio Universitario de Estudios Financieros Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Altamar Private Equity SGIIC SA /Private Equity/
Altamar Private Equity SGIIC SA /Private Equity/ Investment ManagersFinance Altamar Private Equity invests in companies located across the globe. The firm targets businesses operating in the life sciences sector including biotechnology, infrastructure, medical devices, diagnostics, genomics, and digital health. It provides equity and debt financing for buyouts, secondary, special situations, and early to growth stage capital requirements. It also makes co-investments. | Finance |
